Geriatric assessment and its consequences
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hutchins LF et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341(27):2061–2067
Hurria A et al (2014) Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol 32(24):2587–2594
Green AK et al (2022) Clinical trial participation among older adult medicare fee-for-service beneficiaries with cancer. JAMA Oncol 8(12):1786–1792
Sedrak MS et al (2021) Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin 71(1):78–92
Schmitt J et al (2023) Initial cancer treatment in certified versus non-certified hospitals-results of the wizen comparative cohort study. Dtsch Ärztebl Int
Cherny NI et al (2014) Words matter: distinguishing “personalized medicine” and “biologically personalized therapeutics”. J Natl Cancer Inst 106(12)
Kolb G, Bokemeyer C, Wedding U (2020) Geriatrisches assessment integration ins tumorboard. Dtsch Ärztebl 117(27–28):A1382–A1383
Wildiers H et al (2014) International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32(24):2595–2603
Decoster L et al (2015) Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsdagger. Ann Oncol 26(2):288–300
Garcia MV et al (2021) Screening tools for identifying older adults with cancer who may benefit from a geriatric assessment: a systematic review. JAMA Oncol 7(4):616–627
Chon J et al (2023) Validity of a self-administered G8 screening test for older patients with cancer. J Geriatr Oncol 14(7):101553
Culakova E et al (2023) Effects of a geriatric assessment intervention on patient-reported symptomatic toxicity in older adults with advanced cancer. J Clin Oncol 41(4):835–846
Mohile SG et al (2021) Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet 398(10314):1894–1904
Hamaker ME, Rostoft S (2021) Geriatric assessment in older patients with cancer: a new standard of care. Lancet 398(10314):1853–1855
Li D et al (2021) Geriatric Assessment-Driven Intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol 7(e214158):11
Montroni I et al (2022) Quality of life in older adults after major cancer surgery: the GOSAFE international study. J Natl Cancer Inst 114(7):969–978
Extermann M (2021) Living longer and better with haematological malignancies: a promise for older adults too? Lancet Haematol 8(11):e784–e786
Cordoba R et al (2021) A comprehensive approach to therapy of haematological malignancies in older patients. Lancet Haematol 8(11):e840–e852
Goede V et al (2021) Frailty assessment in the care of older people with haematological malignancies. 2(11):736–745
Kennedy VE, Olin RL (2021) Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care. Lancet Haematol 8(11):e853–e861
Wedding U (2021) Palliative care of patients with haematological malignancies: strategies to overcome difficulties via integrated care. Lancet Healthy Longev 2(11):746–753
Dale W et al (2023) Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol 41(26):4293–4312
Williams GR et al (2023) Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline questions and answers. JCO Oncol Pract 19(9):718–723
Nipp RD, Subbiah IM, Loscalzo M (2021) Convergence of geriatrics and palliative care to deliver personalized supportive care for older adults with cancer. J Clin Oncol 39(19):2185–2194
Wildiers H et al (2013) End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer—alliance for clinical trials in oncology—international society of geriatric oncology position article. J Clin Oncol 31(29):3711–3718
https://www.krebsdaten.de/Krebs/DE/Datenbankabfrage/datenbankabfrage_stufe1_node.html. Zugegriffen: 3. Okt. 2023
Ergebnisbericht Tab. 5/Seite 23. https://innovationsfonds.g-ba.de/beschluesse/wizen-wirksamkeit-der-versorgung-in-onkologischen-zentren.111. Zugegriffen: 2. Okt. 2023